Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system. It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy.This report covers the present scenario and the growth prospects of the infertility services market in the US for 2017-2021. To calculate the market size, the report considers the services carried out during treatment via infertility drugs and assisted reproductive technology (ART) services.

PART 01: Executive summary 6

PART 02: Scope of the report 17

Market overview 17

Vendor analysis 17

Top-vendor offerings 19

PART 03: Market research methodology 21

Research methodology 21

Economic indicators 21

PART 04: Introduction 22

Key market highlights 22

PART 05: Market landscape 27

Market overview 27

Market size and forecast 30

Five forces analysis 35

PART 06: Market segmentation by underlying cause 36

PART 07: Market segmentation by services 41

Market overview 41

ART services market in US 42

Infertility drugs services market in US 46

PART 08: Market drivers 48

PART 09: Impact of drivers 53

PART 10: Market challenges 54

PART 11: Impact of drivers and challenges 58

PART 12: Market trends 59

PART 13: Vendor landscape 62

Competitive scenario 62

Other prominent vendors 62

PART 14: Key Vendor Analysis 65

CARE Fertility 65

CooperSurgical 67

Ferring Pharmaceuticals 69

Monash IVF 72

Merck 74

Vitrolife 76

PART 15: Appendix 78

List of abbreviations 78

PART 16: Explore Technavio 79